Home Cart 0 Sign in  
X

[ CAS No. 20098-14-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 20098-14-0
Chemical Structure| 20098-14-0
Chemical Structure| 20098-14-0
Structure of 20098-14-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 20098-14-0 ]

Related Doc. of [ 20098-14-0 ]

Alternatived Products of [ 20098-14-0 ]

Product Details of [ 20098-14-0 ]

CAS No. :20098-14-0 MDL No. :MFCD00192211
Formula : C10H14O2 Boiling Point : -
Linear Structure Formula :- InChI Key :TZBDEVBNMSLVKT-UHFFFAOYSA-N
M.W : 166.22 Pubchem ID :64184
Synonyms :
Kemantane;5-Hydroxy-2-adamantanone
Chemical Name :5-Hydroxyadamantan-2-one

Calculated chemistry of [ 20098-14-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.9
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.24
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.6
Log Po/w (XLOGP3) : 0.54
Log Po/w (WLOGP) : 1.13
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 1.78
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.21
Solubility : 10.2 mg/ml ; 0.0616 mol/l
Class : Very soluble
Log S (Ali) : -0.89
Solubility : 21.2 mg/ml ; 0.127 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.25
Solubility : 9.3 mg/ml ; 0.056 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.81

Safety of [ 20098-14-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 20098-14-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 20098-14-0 ]
  • Downstream synthetic route of [ 20098-14-0 ]

[ 20098-14-0 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 700-58-3 ]
  • [ 108-24-7 ]
  • [ 39751-07-0 ]
  • [ 20098-14-0 ]
  • [ 63382-10-5 ]
  • [ 19214-00-7 ]
Reference: [1] Synthetic Communications, 1999, vol. 29, # 18, p. 3221 - 3225
  • 2
  • [ 700-58-3 ]
  • [ 20098-14-0 ]
YieldReaction ConditionsOperation in experiment
74%
Stage #1: at 60℃; for 74.25 h; Cooling with ice
Stage #2: for 1 h; Heating
Step (i): Preparation of compound of formula (11)Adamantanone (50 grams, 333 mmol) was added with stirring to nitric acid (98percent, 440 mL) at ice bath temperature over a period of 15 minutes. The reaction mixture was stirred at room temperature for 72 hours and then heated at 60 °C, for 2 hours until most of the nitrogen dioxide evaporated. Excess nitric acid was distilled off under reduced pressure. The light yellow oil solidified upon cooling. The reaction mixture was diluted with water (200 mL) and concentrated sulphuric acid (75 mL). The resultant clear yellow solution was heated on the steam bath in a hood for 1 hour. The reaction mixture was neutralized with 30percent aqueous sodiumhydroxide solution, and while warm, extracted with chloroform. The extracts were combined, washed with brine solution and concentrated in vacuum. The crude product was dissolved in dichloromethane ( 15 mL) and hexane was added until no more precipitate was formed. The solid material was isolated by filtration and dried under vacuum to obtain compound of formula (11) (40.9 grams). Yield: 74 percent. Melting Range: 278.8-300 °C; -NMR (CDCI3): δ 2.69 (bs, 2H), 2.36-2.32 (m, 2H), 2.12-2.02 (m, 2H), 2.02-1 :88 (m, 6H), 1.80- 1.68 (m, 1H).IR: 3410, 2929, 2855, 2645, 1725, 1539, 1452, 1351, 1288, 1 1 16, 1055, 927, 900, 797;Mass (m/z): 167 [Μ+Η+].
70%
Stage #1: With nitric acid In water at 0 - 60℃; for 74.25 h;
Stage #2: With sulfuric acid In water for 1 h; Heating / reflux
Adamantanone (12 g, 80 mmol) was added under stirring to nitric acid (98percent, 100 mL) at ice bath temperature over a period of 15 minutes. The reaction mixture was stirred at room temperature for 72 h and then heated to 60 °C, for 2 h until most of the nitrogen dioxide evaporated. Excess nitric acid was distilled off under reduced pressure. The light yellow oil solidified upon cooling (NO3 adduct of the hydroxyketone). Water (40 mL) and cone. H2SO4 (98percent, 15 mL) were added. The resulting clear yellow solution was heated on the steam bath in a hood (nitrous fumes) for 1 h. The solution was then cooled and extracted with a 2:1 mixture of n-hexane and diethylether to remove unreacted adamantanone (1.0 g). The acid layer was neutralized with 30percent aq. NaOH solution, and while warm, extracted with chloroform. The extracts were combined, washed with brine solution, and concentrated in vacuum. The crude product was dissolved in CH2Cl2 (15 mL) and hexane was added until no more precipitate was formed. The solid material was isolated by filtration and dried to get 5-hydroxy-adamantan-2-one. Yield: 9.0 g (70percent). Solid; M.R: 278.8-300 °C (decomposes) m/z (M+l) 167; 1H NMR (CDCl3) 300 MHz δ 2.70-2.55 (m, 2H)5 2.36-2.32 (m5 IH), 2.11-1.93 (m, 10H). 13C NMR (CDCl3) 75 MHz δ 217.0, 66.7, 46.7, 46.6, 44.7 (2C), 43.8, 37.9 (2C), 29.5.
Reference: [1] Russian Journal of Organic Chemistry, 2009, vol. 45, # 8, p. 1137 - 1142
[2] Journal of Organic Chemistry, 1983, vol. 48, # 7, p. 1099 - 1101
[3] Patent: WO2011/30349, 2011, A1, . Location in patent: Page/Page column 23-24
[4] Patent: WO2007/113634, 2007, A1, . Location in patent: Page/Page column 49
[5] Chemical Communications, 2014, vol. 50, # 2, p. 186 - 188
[6] Synthesis, 1972, p. 374 - 375
[7] Organic Letters, 2003, vol. 5, # 16, p. 2943 - 2946
[8] Synthetic Communications, 1984, vol. 14, # 1, p. 65 - 68
[9] Russian Journal of Organic Chemistry, 2002, vol. 38, # 8, p. 1125 - 1129
[10] Patent: US6461876, 2002, B1,
[11] Patent: US2004/77018, 2004, A1,
[12] Patent: US7422908, 2008, B2,
[13] Patent: EP2048140, 2009, A1, . Location in patent: Page/Page column 13
[14] Journal of Molecular Catalysis B: Enzymatic, 2013, vol. 94, p. 111 - 118
  • 3
  • [ 700-58-3 ]
  • [ 20098-14-0 ]
  • [ 73346-81-3 ]
Reference: [1] Journal of Molecular Catalysis B: Enzymatic, 2013, vol. 94, p. 111 - 118
  • 4
  • [ 700-58-3 ]
  • [ 524-38-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6229050, 2001, B1,
  • 5
  • [ 700-58-3 ]
  • [ 524-38-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6229050, 2001, B1,
[2] Patent: US6229050, 2001, B1,
  • 6
  • [ 700-58-3 ]
  • [ 524-38-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6486330, 2002, B1,
  • 7
  • [ 700-58-3 ]
  • [ 524-38-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6229050, 2001, B1,
  • 8
  • [ 20098-20-8 ]
  • [ 20098-14-0 ]
  • [ 41171-83-9 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 10, p. 2366 - 2369
  • 9
  • [ 700-58-3 ]
  • [ 524-38-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6229050, 2001, B1,
  • 10
  • [ 700-58-3 ]
  • [ 7664-93-9 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US5395846, 1995, A,
  • 11
  • [ 24759-97-5 ]
  • [ 20098-14-0 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 26, p. 4649 - 4652
  • 12
  • [ 156639-58-6 ]
  • [ 20098-14-0 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 26, p. 4649 - 4652
  • 13
  • [ 768-95-6 ]
  • [ 20098-14-0 ]
Reference: [1] Patent: US6429314, 2002, B1,
  • 14
  • [ 20098-20-8 ]
  • [ 20098-14-0 ]
Reference: [1] Russian Journal of Organic Chemistry, 2015, vol. 51, # 2, p. 184 - 187[2] Zh. Org. Khim., 2015, vol. 51, # 2, p. 196 - 199
  • 15
  • [ 700-58-3 ]
  • [ 108-24-7 ]
  • [ 39751-07-0 ]
  • [ 20098-14-0 ]
  • [ 63382-10-5 ]
  • [ 19214-00-7 ]
Reference: [1] Synthetic Communications, 1999, vol. 29, # 18, p. 3221 - 3225
  • 16
  • [ 110-82-7 ]
  • [ 90125-35-2 ]
  • [ 20098-14-0 ]
Reference: [1] Journal of Organic Chemistry, 2012, vol. 77, # 3, p. 1340 - 1360
  • 17
  • [ 700-58-3 ]
  • [ 20098-14-0 ]
  • [ 21898-84-0 ]
  • [ 41171-83-9 ]
  • [ 19439-20-4 ]
  • [ 19439-20-4 ]
Reference: [1] Chemische Berichte, 1984, vol. 117, # 5, p. 1982 - 1986
  • 18
  • [ 700-57-2 ]
  • [ 20098-14-0 ]
Reference: [1] Tetrahedron, 1968, vol. 24, p. 5369 - 5377
  • 19
  • [ 20098-14-0 ]
  • [ 64-18-6 ]
  • [ 56674-87-4 ]
Reference: [1] Organic Process Research and Development, 2008, vol. 12, # 6, p. 1114 - 1118
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 25, p. 4404 - 4414
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 23, p. 5958 - 5962
[4] Patent: US2006/149070, 2006, A1, . Location in patent: Page/Page column 24
[5] Patent: US2006/148871, 2006, A1, . Location in patent: Page/Page column 5; 6
[6] Patent: EP2172453, 2010, A1, . Location in patent: Page/Page column 12
  • 20
  • [ 20098-14-0 ]
  • [ 79-37-8 ]
  • [ 108-10-1 ]
  • [ 675200-37-0 ]
  • [ 56674-87-4 ]
Reference: [1] Patent: US2008/85469, 2008, A1,
  • 21
  • [ 20098-14-0 ]
  • [ 56674-87-4 ]
Reference: [1] Patent: WO2009/156092, 2009, A2,
  • 22
  • [ 20098-14-0 ]
  • [ 20098-17-3 ]
Reference: [1] Journal of Organic Chemistry, 1982, vol. 47, # 13, p. 2520 - 2525
[2] Organic Letters, 2010, vol. 12, # 2, p. 332 - 335
[3] Tetrahedron, 1968, vol. 24, p. 5369 - 5377
[4] Patent: EP2048140, 2009, A1, . Location in patent: Page/Page column 14
  • 23
  • [ 20098-14-0 ]
  • [ 38433-24-8 ]
  • [ 20098-17-3 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1987, vol. 52, # 8, p. 2028 - 2034
Same Skeleton Products
Historical Records